Folate-binding Protein Is a Marker for Ovarian Cancer

Cancer Research

Volumn 51, Issue 19, 1991, Pages 5329-5338

  Campbell, Ian G ^a   Jones, Tania A ^a   Foulkes, William D ^a   Trowsdale, John ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FOLATE BINDING PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY;

ARTICLE; CANCER CELL CULTURE; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CARRIER PROTEINS; CELL LINE; CHROMOSOMES, HUMAN, PAIR 11; COLONIC NEOPLASMS; DNA; FEMALE; FLOW CYTOMETRY; HUMAN; MICE; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; POLY A; POLYMORPHISM (GENETICS); RESTRICTION MAPPING; RNA; RNA, MESSENGER; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0025949661     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Bast, R. C., Jr., Boyer, C. M., Olt, G. J., Berchuck, A., Soper, J. T., Clarke-Pearson, D., Xu, F. J., and Ramakrishnan, S. identification of markers for early detection of epithelial ovarian cancer. In: F. Sharp, W. P. Mason, and R. E. Leake (eds.), Ovarian Cancer Biological and Therapeutic Challenges, pp. 265-275. London, England: Chapman and Hall Medical, 1990.
2. Bast, R. C., Jr., Feeney, M., Lazarus, H., Nadler, L. M., Colvin, R. B., and Knapp, R. C. Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest., 68: 1331-1337,1981.
3. Bast, R. C., Jr., Hunter, V., and Knapp, R. C. Pros and cons of gynecological tumor markers. Cancer (Phila.), 60: 1984-1992,1987.
4. Hakomori, S. Tumor-associated carbohydrate antigens. Annu. Rev. Immunol., 2:103-126,1984.
5. Girling, A., Bartkova, J., Burchell, J., Gendler, S., Gillett, C., and Taylor-Papadimitriou, J. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int. J. Cancer, 43:1072-1076, 1989.
6. Miotti, S., Canevari, S., Menard, S., Mezzanzanica, D., Porro, G., Pupa, S. M., Reganzzoni, M., Tagliabue, E., and Colnaghi, M. I. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int. J. Cancer, 39: 297-303, 1987.
7. Veggian, R., Fasolato, S., Menard, S., Minucci, D., Pizzetti, P., Regazzoni, M., Tagliabue, E., and Colnaghi, M. I. Immunohistochemical reactivity of a monoclonal antibody prepared against human ovarian carcinoma on normal and pathological female genital tissues. Tumori, 75: 510-513,1989.
8. Boerman, O. C., van Niekerk, C. C., Makkink, K., Hanselaar, T. G. J. M., Kenemans, P., and Poels, L. G. Comparative immunohistochemical study of four monoclonal antibodies directed against ovarian carcinoma-associated antigens. Int. J. Gynecol. Pathol., 10: 15-25, 1991.
9. van Niekerk, C. C., Jap, P. H. K., Thomas, C. M. G., Smeets, D. F. C. M., Ramaekers, F. C. S., and Poels, L. G. Marker profile of mesothelial cells versus ovarian carcinoma cells. Int. J. Cancer, 43:1065-1071, 1989.
10. Mattes, M. J., Major, P. P., Goldenberg, D. M., Dion, A. S., Hutter, R. V. P., and Klein, K. M. Patterns of antigen distribution in human carcinomas. Cancer Res., 50:880-884, 1990.
11. Fogh, J., Wright, W. C., and Lovelass, J. D. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst., 58: 209-214, 1977.
12. Langdon, S. P., Lawrie, S. S., Hay, F. G., Hawkes, M. M., McDonald, A., Hayward, I. P., Schol, D. J., Hilgers, J., Leonard, R. C. F., and Smyth, J. F. Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res., 48:6166-6172, 1988.
13. Hill, B. T., Whelan, R. D. H., Gibby, E. M., Sheer, D., Hosking, L. K., Shetland, S. A., and Rupniak, T. Establishment and characterization of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studies. Int. J. Cancer, 39:219-225, 1987.
14. Leibovitz, A., Stinson, J. C., McCombs, W. B., III, McCoy, C. E., Mazur, K. C., and Mabry, N. D. Classification of human colorectal adenocarcinoma cell lines. Cancer Res., 36:4562-4569,1976.
15. Fogh, M., and Trempe, G. New human tumor cell lines. In: J. Fogh (ed.), Human Tumor Cells in Vitro, pp. 115-141. New York: Plenum Press, 1975.
16. Tom, B. H., Rutzky, L. P., Jakstys, M. M., Oyasu, R., Kaye, G. I., and Kahan, B. D. Human colorectal adenocarcinoma cells. I. Establishment and description of a new line. In Vitro, 12: 180-191,1976.
17. Drewinco, B., Romsdhal, M. M., Yang, L. Y., Ahearn, M. J., and Trujillo, J. M. Establishment of a human CEA producing colon adenocarcinoma cell line. Cancer Res., 36:467-475, 1976.
18. Dexter, D. L., Barbosa, J. A., and Calabresi, P. AN-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorgenicity in culture human colon carcinoma cells. Cancer Res., 39:1020-1025,1979.
19. Brattain, M. G., Fine, W. D., Khaled, F. M., Thompson, J., and Brattain, D. E. Heterogeneity of malignant cells from human colonic carcinoma. Cancer Res., 41: 1751-1756, 1981.
20. Greenhalgh, D. A., and Kinsella, A. R. c-Ha-ros not c-Ki-ras activation in three tumor cell lines. Carcinogenesis (Lond.), 6: 1533-1535, 1985.
21. Soule, H. D., Vazquez, J., Long, A., Albert, S., and Brennan, M. A human cell line from a pleural efTusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51: 1409-1416, 1973.
22. Kozbor, D., and Croce, C. M. Amplification of the c-myc oncogene in one of five human breast carcinoma cell lines. Cancer Res., 44:438-441, 1984.
23. Santos, E., Traonick, S. R., Aaronson, S. A., Pulciani, S., and Barbacid, M. Human EJ bladder carcinoma oncogene is homologue of BALB-and Harvey-MSV transforming gene. Nature (Lond.), 298:343-347, 1982.
24. Rasheed, S., Nelson-Rees, W. A., Toth, E. M., Arnstein, P., and Gardner, M. B. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer (Phila.), 33: 1027-1033, 1974.
25. Nelson-Rees, W. A., and Flandermeyer, R. R. HeLa cultures defined. Science (Washington DC), 191:96-98,1976.
26. Minowasa, J., Ohnuma, T., and Moore, G. E. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst., 49: 891-895, 1972.
27. Kozlowski, J. M., Fidler, I. J., Campbell, D., Xu, Z., Kaighn, M. E., and Hart, I. R. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res., 44: 3522-3529, 1986.
28. Brodsky, F. M., Parham, P., Barnstable, C. J., Crumpton, M. J., and Bodmer, W. F. Monoclonal antibodies for analysis of the HLA system. Immunol. Rev., 47: 3-61, 1979.
29. Jacobs, J. P., Jones, C. M., and Bailie, J. P. Characteristics of a human diploid cell designated MRC-5. Nature (Lond.), 227:168-170, 1970.
30. Erikson, J., Ar-Rushdi, A., Drwinga, H. L., Nowell, P. C., and Croce, C. M. Transcriptional activation of the translocated c-myc oncogene in Burkitt lymphoma. Proc. Natl. Acad. Sci. USA, 80: 820-824, 1983.
31. Flugel, R. M., Crefeld, T., and Munk, K. Detection of SV40 antigen with labelled antibodies: radioimmunoassay and autoradiography. Int. J. Cancer, 19:656-663, 1977.
32. Seed, B. An LFA-3 cDNA encodes a phospholipid membrane protein homologous to its receptor CD2. Nature (Lond.), 329:840-842,1987.
33. Dailey, L., and Basllico, C. Sequences in the polyomavirus DNA regulatory region involved in viral replication and early gene expression. J. Virol., 54: 739-749, 1985.
34. Chu, G., Hayakawa, H., and Berg, P. Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res., 15: 1311-1326,1987.
35. Aruffo, A., and Seed, B. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA, 84:8573-8577, 1987.
36. Bimboim, H. C., and Doly, J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res., 7: 1513-1523, 1979.
37. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual. Cold Spring, NY: Cold Spring Harbor Laboratory, 1982.
38. Croce, C. M., and Koprowski, H. Somatic cell hybrids between mouse peritoneal macrophages and SV-40 transformed human cells. J. Exp. Med., 140: 1221-1229, 1974.
39. Solomon, E., Bobrow, M., Goodfellow, P. N., Bodmer, W. F., Swallow, D. M., Povey, S., and Noel, B. Human gene mapping using an X/autosome translocation. Somat. Cell Genet., 2: 125-140,1976.
40. Edwards, Y. H., Parkar, M., Povey, S., West, L. F., Parrington, F. M., and Solomon, E. Human myosin heavy chain genes assigned to chromosome 17 using a human cDNA clone as probe. Ann. Hum. Genet., 49:101-109,1985.
41. Jones, E. A., Goodfellow, P. N., Kennett, R. H., and Bodmer, W. F. The independent expression of HLA and 02 microglobulin on human-mouse hybrids. Somat. Cell Genet., 2:483-496, 1976.
42. Hobart, M. J., Rabbitts, T. H., Goodfellow, P. N., Solomon, E., Chambers, S., Spurr, N., and Povey, S. Immunoglobulin heavy chain genes map to chromosome 14. Ann. Hum. Genet., 45: 331-335, 1981.
43. Jones, C., Bill, J., Larizza, L., Bym, G., Geedfellow, P., and Tunnacliffe, A. Relationship between genes on human chromosome 11, encoding cell surface antigens. Somat. Cell Mol. Genet., 10:423-428, 1984.
44. Edwards, Y., West, L., Van Heyningen, V., Cowell, J., and Goldberg, E. Regional localization of the sperm-specific lactate dehydrogenase, LDHC, gene on human chromosome 11. Ann. Hum. Genet., 53: 215-219, 1989.
45. Chiang, Y. L., Ley, T. J., Sanders-Haigh, L., and Anderson, W. F. Human globin gene expression in hybrid 2S MEL x human fibroblast cells. Somat. Cell Mol. Genet., 10: 399-407, 1984.
46. Pinkel, D., Landegent, J., Collins, C., Fuscoe, J., Segraves, R., Lucas, J., and Gray, J. Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc. Natl. Acad. Sci. USA, 85: 9138-9142, 1985.
47. Lichter, P., Tang, C., Call, K., Hermanson, G., Evans, G. A., Housman, D., and Ward, D. C. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science (Washington DC), 247: 264-268, 1989.
48. Harnden, D. G., and Klinger, H. P. An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger, 1985.
49. Ratnam, M., Marquardt, H., Duhring, J. L., and Freisheim, J. H. Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA. Biochemistry, 28: 8249-8254, 1989.
50. Elwood, P. C. Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture (KB) cells. J. Biol. Chem., 264: 14893-14901, 1989.
51. Lacey, S. W., Sanders, J. M., Rothberg, K. G., Anderson, R. G. W., and Kamen, B. A. Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J. Clin. Invest., 84:715-720,1990.
52. Sadasivan, E., and Rothenberg, S. P. The complete amino acid sequence of a human folate binding protein from KB cells determined from the cDNA. J. Biol. Chem., 264: 5806-5811, 1989.
53. Waye, J. S., Greig, G. M., and Willard, W. F. Detection of novel centromeric polymorphisms associated with alpha satellite DNA from human chromosome 11. Hum. Genet., 77: 151-156, 1987.
54. Kamen, B. A., and Capdevila, A. Receptor-mediated folate accumulation is regulated by cellular folate content. Proc. Natl. Acad. Sci. USA, 83: 5983-5987, 1986.
55. Jansen, G., Kathmann, I., Rademaker, B. C., Braakhuis, B. J. M., Westerhof, G. R., Rijksen, G., and Schornagel, J. H. Expression of a folate binding protein in LI 210 cells grown in low folate medium. Cancer Res., 49: 1959-1963, 1989.
56. Henderson, G. B. Folate binding proteins. Annu. Rev. Nutr., 10: 319-335, 1990.
57. Kane, M. A., and Waxman, S. Biology of disease: role of folate binding proteins in folate metabolism. Lab. Invest., 60:737-746, 1989.
58. Selhub, J., Nakamura, S., and Carone, F. A. Renal folate absorption and the kidney folate binding protein. II. Microinfusion studies. Am. J. Physiol., 252: F757-F760, 1987.
59. McHugh, M., and Cheng, Y. C. Demonstration of a high-afTinity folate binder in human cell membranes and its characterization in human KB cells. J. Biol. Chem., 254: 11312-11318,1979.
60. Jansen, G., Westerhof, G. R., Kathmann, I., Rademaker, B. C., Rijksen, G., and Schornagel, J. H. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate. Cancer Res., 49: 2455-2459,1989.
61. Henderson, G. B., Tsuji, J. M., and Kumar, H. P. Mediated uptake of folate by a high affinity binding protein in sub-lines of LI210 cells adapted to nanomolar concentrations of folate. J. Membr. Biol., 101: 247-258, 1988.
62. Rothberg, K. G., Ying, Y., Kolhouse, J. F., Kamen, B. A., and Anderson, R. G. W. The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway. J. Cell Biol., 110: 637-649, 1990.
63. Kane, M. A., Elwood, P. C., Portillo, R. M., Antony, A. C., Najfeld, V., Finley, A., Waxman, S., and Kolhouse, J. F. Influence on immunoreactive folate binding proteins of extracellular folate concentration in cultured human cells. J. Clin. Invest., 81: 1398-1406, 1988.
64. Ford, J. E. Some observations on the possible nutritional significance of vitamin B12 and folate binding proteins in milk. Br. J. Nutr., 31: 335-342, 1974.
65. Luhrs, C. A., and Slomiany, B. L. A human membrane-associated folate binding protein is anchored by a glycosyl-phosphatidylinositol tail. J. Biol. Chem., 264:21446-21449, 1989.
66. Alberti, S., Miotti, S., Fomaro, M., Mantovani, L., Walter, S., Canevari, S., Menard, S., and Colnaghi, M. I. The Ca-MOvl8 molecule, a cell-surface marker of human ovarian carcinomas, is anchored to the cell membrane by phosphatidylinositol. Biochem. Biophys. Res. Commun., 171: 1051-1055, 1990.
67. Low, M. G., and Saltiel, A. R. Structural and functional roles of glycosyl-phosphatidylinositol in membranes. Science (Washington DC), 239: 268-275, 1988.
68. Low, M. G., and Prasad, A. R. S. A phospholipase D specific for the phosphatidylinositol anchor of cell-surface proteins is abundant in plasma. Proc. Natl. Acad. Sci. USA, 85:980-984, 1988.
69. Low, M. G. Glycosyl-phosphatidylinositol: a versatile anchor for cell surface proteins. FASEB J., 3:1600-1608, 1990.
70. Krumdieck, C. L., Boots, L. R., Cornwell, P. E., and Butterworth, C. E., Jr. Estrogen stimulation of conjugase activity in the uterus of ovariectomized rats. Am. J. Clin. Nutr., 28: 530-534, 1976.
71. Krumdieck, C. L., Boots, L. R., Cornwell, P. E., and Butterworth, C. E., Jr. Cyclic variations in folate composition and pteroylpolyglutamyl hydrolase (conjugase) activity of the rat uterus. Am. J. Clin. Nutr., 29:288-294, 1976.
72. Holm, J., Hansen, S. I., and Lyngbye, J. High and low affinity binding of folate to proteins in serum of pregnant women. Biochim. Biophys. Acta, 629: 539, 1980.
73. Joshi, U. M., Virkar, K. D., Amatayakul, K., Singkamani, R., Bamji, M. S., Prema, K., Whitehead, T. P., Belsey, M. A., Hall, P., Parker, R. A., et al Impact of hormonal contraceptives vis-a-vis non-hormonal factors on the vitamin status of malnourished women in India and Thailand. Hum. Nutr. Clin. Nutr., 40: 205-220, 1986.
74. Rochman, H., Selhub, J., and Karrison, T. Folate binding protein and estrogen receptor in breast cancer. Cancer Detect. Prev., 8:71, 1985.
75. Butterworth, C. E., Jr., Hatch, K. D., Gore, H., Mueller, H., and Krumdieck, C. L. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am. J. Clin. Nutr., 35:73-82, 1982.
76. Leff, S. E., and Rosenfeld, M. G. Complex transcriptional units: diversity in gene expression by alternative RNA processing. Annu. Rev. Biochem., 55: 1091-1117, 1986.
77. Chobert, M. N., Lahuna, O., Lebargy, F.M. Kurauchi, O., Darbouy, M., Bemaudin, J. F., Guellaen, G., Barouki, R., and Laperche, Y. Tissue specific expression of two 7-glutamyl transpeptidase mRNAs with alternative 5' ends encoded by a single copy gene in the rat. J. Biol. Chem., 265: 2352-2357, 1990.
78. Low, W. L., Jr., Roberts, C. T., Jr., Lasky, S. R., and LeRoith, D. Differential expression of alternative 5' untranslated regions in mRNAs encoding rat insulin-like growth factor. Proc. Natl. Acad. Sci. USA, 84:8946-8950,1987.
79. Henderson, G. B., and Strauss, B. P. Growth inhibition by homofolate in tumor cells utilizing a high-affinity folate binding protein as a means for folate internalization. Biochem. Pharmacol., 39:2019-2025,1990.
80. Lund, B., and Hansen, H. H. Chemotherapy in ovarian cancer. Cancer Surv., 8:681-691, 1990.
81. Scanlon, K. J., Newman, E. M., Lu, Y., and Priest, D. G. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc. Natl. Acad. Sci. USA, 83:8923-8925,1986.
82. Lu, Y., Han, J., and Scanlon, K. J. Biochemical and molecular properties of cisplatin-resistant A2780 cells grown in folinic acid. J. Biol. Chem., 263: 4891-4894,1988.
83. Casey, G., Smith, R., McGillvray, D., Peters, G., and Dickson, C. Characterization and chromosome assignment of the homolog of int-2, a potential proto-oncogene. Mol. Cell Biol., 6:502-510,1986.
84. Yoshida, M. C., Wada, M., Satoh, H., Yoshida, T., Sakamoto, H., Miyagawa, K., Yokota, J., Koda, T., Kakinuma, M., Sugimura, T., and Terada, M. Human HST1 (HSTF1) gene maps to chromosome band llq and co-amplifies with the INT2 gene in human cancer. Proc. Natl. Acad. Sci. USA, 85:4861-4864, 1988.
85. Barker, H. M., Jones, T. A., Da Cruze Silva, E. F., Spurr, N. K., Sheer, D., and Cohen, P. T. W. Localization of the gene encoding a type I protein phosphatase catalytic subunit to human chromosome band 1 lql3. Genomics, 7:159-166, 1990.
86. Julier, C., Nakamura, Y., Lathrop, M., O'Connell, P., Leppert, M., Litt, M., Mohandas, T., Lalouel, J., and White, R. A detailed genetic map of the long arm of chromosome 11. Genomics, 7:335-345,1990.
87. Zimmermann, W., Ortlieb, B., Friedrich, R., and von Kleist, S. Isolation and characterization of cDNA clones encoding the human carcinoembryonic antigen reveal a highly conserved repeating structure. Proc. Natl. Acad. Sci. USA, 84:2960-2964, 1987.
88. Hotta, H., Ross, A. H., Huebner, K., Isobe, M., Wendebom, S., Chao, M. V., Ricciardi, R. P., Tsujimoto, Y., Croce, C. M., and Koprowski, H. Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res., 48:2955-2962, 1988.
89. Strnad, J., Hamilton, A. E., Beavers, L. S., Gamboa, G. C., Apelgren, L. D., Taber, L. D., Sportsman, J. R., Bumol, T. F., Sharp, J. D., and Gadski, R. A. Molecular cloning and characterization of a human adenocarcinoma/ epithelial cell surface antigen complementary DNA. Cancer Res., 49: 314-317, 1989.